Search research articles
Contact Us
Filters
Showing results (591-600 of 992) with videos related to
Page
of 100
Sort By:
European Journal of Gastroenterology & Hepatology
|
September 18, 2007
Tumor pyruvate kinase isoenzyme type M2 and immunochemical fecal occult blood test: performance in screening for colorectal cancer
Sanna A Mulder, Monique E van Leerdam, Anneke J van Vuuren, et al.
European Journal of Gastroenterology & Hepatology
|
August 6, 2008
Inappropriate prescription of proton pump inhibitors on two pulmonary medicine wards
Evelyn P M van Vliet, Henk J A M Otten, Arjan Rudolphus, et al.
Digestive Diseases and Sciences
|
December 11, 2014
Advances in Fecal Occult Blood Tests: the FIT revolution
Graeme P Young, Erin L Symonds, James E Allison, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis
|
November 1, 2013
Modeling the Adenoma and Serrated pathway to Colorectal CAncer (ASCCA)
Marjolein J E Greuter, Xiang-Ming Xu, Jie-Bin Lew, et al.
Scandinavian Journal of Gastroenterology
|
September 8, 2012
Myo9B is associated with an increased risk of Barrett's esophagus and esophageal adenocarcinoma
Vivianda Menke, Katinka P M Van Zoest, Leon M G Moons, et al.
Gut
|
July 19, 2015
Kyoto global consensus report on Helicobacter pylori gastritis
Kentaro Sugano, Jan Tack, Ernst J Kuipers, et al.
Transplantation
|
June 24, 2006
Superior immunomodulatory effects of intravenous immunoglobulins on human T-cells and dendritic cells: comparison to calcineurin inhibitors
Thanyalak Tha-In, Herold J Metselaar, Hugo W Tilanus, et al.
Cancer Epidemiology
|
April 8, 2011
Prevalence and prognosis of synchronous colorectal cancer: a Dutch population-based study
Sanna A Mulder, Ries Kranse, Ronald A Damhuis, et al.
International Journal of Cancer
|
July 29, 1997
Country-specific constancy by age in cagA+ proportion of Helicobacter pylori infections
G I Pérez-Pérez, N Bhat, J Gaensbauer, et al.
Hepatology (Baltimore, Md.)
|
July 27, 2007
Tumor necrosis factor alpha inhibits the suppressive effect of regulatory T cells on the hepatitis B virus-specific immune response
Jeroen N Stoop, Andrea M Woltman, Paula J Biesta, et al.
Page
of 100
Search research articles
Search
Showing results (591-600 of 992) with videos related to
Sort By:
Page
of 100
European Journal of Gastroenterology & Hepatology
|
September 18, 2007
Tumor pyruvate kinase isoenzyme type M2 and immunochemical fecal occult blood test: performance in screening for colorectal cancer
Sanna A Mulder, Monique E van Leerdam, Anneke J van Vuuren, et al.
European Journal of Gastroenterology & Hepatology
|
August 6, 2008
Inappropriate prescription of proton pump inhibitors on two pulmonary medicine wards
Evelyn P M van Vliet, Henk J A M Otten, Arjan Rudolphus, et al.
Digestive Diseases and Sciences
|
December 11, 2014
Advances in Fecal Occult Blood Tests: the FIT revolution
Graeme P Young, Erin L Symonds, James E Allison, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis
|
November 1, 2013
Modeling the Adenoma and Serrated pathway to Colorectal CAncer (ASCCA)
Marjolein J E Greuter, Xiang-Ming Xu, Jie-Bin Lew, et al.
Scandinavian Journal of Gastroenterology
|
September 8, 2012
Myo9B is associated with an increased risk of Barrett's esophagus and esophageal adenocarcinoma
Vivianda Menke, Katinka P M Van Zoest, Leon M G Moons, et al.
Gut
|
July 19, 2015
Kyoto global consensus report on Helicobacter pylori gastritis
Kentaro Sugano, Jan Tack, Ernst J Kuipers, et al.
Transplantation
|
June 24, 2006
Superior immunomodulatory effects of intravenous immunoglobulins on human T-cells and dendritic cells: comparison to calcineurin inhibitors
Thanyalak Tha-In, Herold J Metselaar, Hugo W Tilanus, et al.
Cancer Epidemiology
|
April 8, 2011
Prevalence and prognosis of synchronous colorectal cancer: a Dutch population-based study
Sanna A Mulder, Ries Kranse, Ronald A Damhuis, et al.
International Journal of Cancer
|
July 29, 1997
Country-specific constancy by age in cagA+ proportion of Helicobacter pylori infections
G I Pérez-Pérez, N Bhat, J Gaensbauer, et al.
Hepatology (Baltimore, Md.)
|
July 27, 2007
Tumor necrosis factor alpha inhibits the suppressive effect of regulatory T cells on the hepatitis B virus-specific immune response
Jeroen N Stoop, Andrea M Woltman, Paula J Biesta, et al.
Page
of 100